Avid Bioservices Inc (CDMO)

[pphmtoolong]

If Peregrine was so attractive, we wouldn't be where we are now. Management needs to make a more compelling case for buying their shares.

No rocket science here. Slash the burn rate. Ink a solid money deal. I welcome other ideas.

After many years here, I can confidently say that preclinical data and attendance at the financial fora will not get much of a move.

The path forward will entail painful layoffs and management pay cuts. I don't wish them on anyone, but here we are.

GLTA, Paul